Antimicrobial Agent Exposure and the Emergence and Spread of Resistant Microorganisms: Issues Associated with Study Design

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 2012 Dec 27

PMID 23268203

Citations 19

Authors

C Angebault

A Andremont

Affiliations

Soon will be listed here.

Abstract

Antibiotics are essential agents that have greatly reduced human mortality due to infectious diseases. Their use, and sometimes overuse, have increased over the past several decades in humans, veterinary medicine and agriculture. However, the emergence of resistant pathogens is becoming an increasing problem that could result in the re-emergence of infectious diseases. Antibiotic prescription in human medicine plays a key role in this phenomenon. Under selection pressure, resistance can emerge in the commensal flora of treated individuals and disseminate to others. However, even if the effects of antimicrobial use on resistance is intuitively accepted, scientific rationales are required to convince physicians, legislators and public opinion to adopt appropriate behaviours and policies. With this review, we aim to provide an overview of different epidemiological study designs that are used to study the relationship between antibiotic use and the emergence and spread of resistance, as well as highlight their main strengths and weaknesses.

Citing Articles

Diterpenoids from Isodon serra with promising anti-MRSA activities.

Li B, Hu J, Ji C, Wu J Int Microbiol. 2024; .

PMID: 39307851 DOI: 10.1007/s10123-024-00599-3.

Antibiotic appropriateness at outpatient settings in Ethiopia: the need for an antibiotic stewardship programme.

Abebe R, Ayal B, Alemu M, Zeleke T Drugs Context. 2024; 13.

PMID: 38742144 PMC: 11090269. DOI: 10.7573/dic.2023-12-2.

Comparative Evaluation of Effectiveness of Nisin, Amoxicillin/Clavulanic Acid (Augmentin) and Chlorhexidine on E. Faecalis as an Intracanal Irrigant: An Study.

Khan M, Samant P, Chauhan R, Khan R, Siddiqui S, Sachan S J Pharm Bioallied Sci. 2023; 15(Suppl 2):S1317-S1320.

PMID: 37693982 PMC: 10485529. DOI: 10.4103/jpbs.jpbs_105_23.

Antibiotic Use during Pregnancy in South Korea Using 2011-2020 National Health Insurance Claims Data.

Chae J, Choi J, Kim B, Kim D Antibiotics (Basel). 2023; 12(8).

PMID: 37627662 PMC: 10451209. DOI: 10.3390/antibiotics12081242.

Important Roles and Potential Uses of Natural and Synthetic Antimicrobial Peptides (AMPs) in Oral Diseases: Cavity, Periodontal Disease, and Thrush.

Luong A, Buzid A, Luong J J Funct Biomater. 2022; 13(4).

PMID: 36278644 PMC: 9589978. DOI: 10.3390/jfb13040175.

References

Kaye K, Harris A, Samore M, Carmeli Y . The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol. 2005; 26(4):346-51. DOI: 10.1086/502550. View

Feikin D, Dowell S, Nwanyanwu O, Klugman K, Kazembe P, Barat L . Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine. J Infect Dis. 2000; 181(4):1501-5. DOI: 10.1086/315382. View

Lau J, Ioannidis J, Schmid C . Quantitative synthesis in systematic reviews. Ann Intern Med. 1998; 127(9):820-6. DOI: 10.7326/0003-4819-127-9-199711010-00008. View

Stroup D, Thacker S, Olson C, Glass R, Hutwagner L . Characteristics of meta-analyses related to acceptance for publication in a medical journal. J Clin Epidemiol. 2001; 54(7):655-60. DOI: 10.1016/s0895-4356(00)00362-0. View

Harris A, Samore M, Lipsitch M, Kaye K, Perencevich E, Carmeli Y . Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis. 2002; 34(12):1558-63. DOI: 10.1086/340533. View

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Rodriguez-Bano J, Alcala J, Cisneros J, Grill F, Oliver A, Horcajada J . Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med. 2008; 168(17):1897-902. DOI: 10.1001/archinte.168.17.1897. View

Bliziotis I, Samonis G, Vardakas K, Chrysanthopoulou S, Falagas M . Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis. 2005; 41(2):149-58. DOI: 10.1086/430912. View

Schulz K . Randomised trials, human nature, and reporting guidelines. Lancet. 1996; 348(9027):596-8. DOI: 10.1016/S0140-6736(96)01201-9. View

10.

Tacconelli E, De Angelis G, Cataldo M, Pozzi E, Cauda R . Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother. 2007; 61(1):26-38. DOI: 10.1093/jac/dkm416. View

11.

Bradley S, Wilson A, Allen M, Sher H, Goldstone A, Scott G . The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. J Antimicrob Chemother. 2001; 43(2):261-6. DOI: 10.1093/jac/43.2.261. View

12.

Rothman K, Greenland S . Causation and causal inference in epidemiology. Am J Public Health. 2005; 95 Suppl 1:S144-50. DOI: 10.2105/AJPH.2004.059204. View

13.

Lafaurie M, Porcher R, Donay J, Touratier S, Molina J . Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study. J Antimicrob Chemother. 2012; 67(4):1010-5. DOI: 10.1093/jac/dkr555. View

14.

Beekmann S, Diekema D, Heilmann K, Richter S, Doern G . Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study. Eur J Clin Microbiol Infect Dis. 2006; 25(5):335-9. DOI: 10.1007/s10096-006-0137-8. View

15.

Kouyos R, Abel Zur Wiesch P, Bonhoeffer S . Informed switching strongly decreases the prevalence of antibiotic resistance in hospital wards. PLoS Comput Biol. 2011; 7(3):e1001094. PMC: 3048378. DOI: 10.1371/journal.pcbi.1001094. View

16.

Lau J, Ioannidis J, Schmid C . Summing up evidence: one answer is not always enough. Lancet. 1998; 351(9096):123-7. DOI: 10.1016/S0140-6736(97)08468-7. View

17.

Madaras-Kelly K, Remington R, Lewis P, Stevens D . Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect Control Hosp Epidemiol. 2006; 27(2):155-69. DOI: 10.1086/500060. View

18.

Olsen J . What characterises a useful concept of causation in epidemiology?. J Epidemiol Community Health. 2003; 57(2):86-8. PMC: 1732370. DOI: 10.1136/jech.57.2.86. View

19.

Schulz K, Grimes D . Blinding in randomised trials: hiding who got what. Lancet. 2002; 359(9307):696-700. DOI: 10.1016/S0140-6736(02)07816-9. View

20.

Razazi K, Derde L, Verachten M, Legrand P, Lesprit P, Brun-Buisson C . Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit. Intensive Care Med. 2012; 38(11):1769-78. DOI: 10.1007/s00134-012-2675-0. View